References
- Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New Fundamentals in Hemostasis. Physiol Rev. 2013;93:327-58. DOI: 10.1152/physrev.00016.2011
- Bonar R, Favaloro EJ, Adcock DM. Quality in coagulation and haemostasis testing. Biochem Med (Zagreb). 2010;20:184-99. DOI: 10.11613/BM.2010.023
- Harris NS, Bazydlo LAL, Winter WE. A Primer on Haemostasis for Clinical Chemists.Clinical Laboratory News 2012. Available at: https://www.aacc.org/publications/cln/articles2012/January/coagulation-tests. Accessed March 17th 2016.
- Chandler WL, ed. Initial evaluation of hemostasis: reagent and method selection. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 63-71. DOI: 10.1002/9781444303575.ch7
- Favaloro EJ, Funk DM, Lippi G. Pre-analytical variables in coagulation testing associated with diagnostic errors in haemostasis. Lab Med. 2012;43:1-10. DOI: 10.1309/LM749BQETKYPYPVM
- Bronić A, Coen Herak D, Margetić S, Milić M. Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Biochem Med (Zagreb). 2017;27:199-216. DOI: 10.11613/BM.2017.022
- Lippi G, Favaloro EJ, eds. Causes of errors in medical laboratories. In Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 22-31. DOI: 10.1002/9781118543467.ch3
- Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thromb J. 2016;14:49. DOI: 10.1186/s12959-016-0123-z
- Lippi G, Favaloro EJ. Preanalytical Issues in Hemostasis and Thrombosis Testing. Methods Mol Biol. 2017;1646:29-42. DOI: 10.1007/978-1-4939-7196-1_2
- Nikolac N, Šupak-Smolčić V, Šimundić AM, Ćelap I. Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling. Biochem Med (Zagreb). 2013;23:242-54. DOI: 10.11613/BM.2013.031
- Clinical and Laboratory Standards Institute (CLSI). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline-Fifth Edition. CLSI document H21-A5. Wayne: CLSI; 2008.
- Adcock DM, Kressin DC, Marlar RA. Minimum Specimen Volume Requirements for Routine Coagulation Testing Dependence on Citrate Concentration. Am J Clin Pathol. 1998;109;595-9. DOI: 10.1093/ajcp/109.5.595
- Bennett ST, ed. Collection of Coagulation Specimens. In: Bennett ST, Lehman CM, Rodgers GM, eds. Laboratory Hemostasis - A Practical Guide for Pathologists. Basel: Springer International Publishing Switzerland; 2015. p.19-32. DOI: 10.1007/978-3-319-08924-9_2
- Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Gu- idi GC, Favaloro EJ. Quality Standards for Sample Collection in Coagulation Testing. Semin Thromb Hemost. 2012;38: 565-75. DOI: 10.1055/s-0032-1315961
- Laxson CJ, Titler MG. Drawing coagulation studies from arterial lines; an integrative literature review. Am J Critical Care. 1994;3:16-22. DOI: 10.4037/ajcc1994.3.1.16
- Adcock Funk D, ed. Sample integrity and preanalytical variables. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 45-56. DOI: 10.1002/9781118543467.ch5
- Suchsland J, Friedrich N, Grotevendt A, Kallner A, Lüdemann J, Nauck M, Petersmann A. Optimizing centrifugation of coagulation samples in laboratory automation. Clin Chem Lab Med. 2014;52:1187-91. DOI: 10.1515/cclm-2014-0038
- Marlar RA, Potts MR, Marlar AA. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol. 2006;126:400-5. DOI: 10.1309/RRQKT2JEYV33D19D
- Lippi G, Plebani M, Favarolo EJ. Interference in coagulation testing: Focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost. 2013;39:258-66. DOI: 10.1055/s-0032-1328972
- Adcock Funk DM, Lippi G, Favaloro EJ. Quality Standards for Sample Processing, Transportation, and Storage in Hemostasis Testing. Semin Thromb Hemost. 2012;38:576-85. DOI: 10.1055/s-0032-1319768
- van Geest-Daalderop JH, Mulder AB, Boonman-de Winter LJ, Hoekstra MM, van den Besselaar AM. Preanalytical variables and off-Site blood collection: Influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005;51:561-8. DOI: 10.1373/clinchem.2004.043174
- Favaloro EJ, Soltani S, McDonald J. Potential laboratory misdiagnosis of haemophilia and von Willebrand Disorder due to cold activation of blood samples for testing. Am J Clin Path. 2004;122;686-92. DOI: 10.1309/E4947DG48TVY19C2
- Lima-Oliveira G, Adcock DM, Salvagno GL, Favaloro EJ, Lippi G. Mixing of thawed coagulation samples prior to testing: Is any technique better than another? Clin Biochem. 2016;49:1399-401. DOI: 10.1016/j.clinbiochem.2016.10.009
- Gosselin RC, Honeychurch K, Kang HJ, Dwyre DM. Effects of storage and thawing conditions on coagulation testing. Int J Lab Hematol. 2015;37:551-9. DOI: 10.1111/ijlh.12342
- Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M; British Committee for Standards in Haematology. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol. 2013;35:1-13. DOI: 10.1111/ijlh.12004
- Gardiner C, Kitchen S, Dauer RJ, Kottke-Marchant K, Adcock DM. Recommendations for evaluation of coagulation analyzers. Lab Hematol. 2006;12:32-8. DOI: 10.1532/LH96.05031
- Kitchen S, Preston EF, Olson JD, eds. Internal Quality Control in the hemostasis Laboratory. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 57-64. DOI: 10.1002/9781118543467.ch6
- Preston EF, Kitchen S, Srivastava A, eds. External Quality Assessment in Hemostasis: Its Importance and Significance. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 65-76. DOI: 10.1002/9781118543467.ch7
- Clinical and Laboratory Standard Institute (CLSI). One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline-Second Edition H47-A2, Wayne: CLSI; 2008.
- Tripodi A, ed. Monitoring Oral Anticoagulant Therapy. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 253-63. DOI: 10.1002/9781118543467.ch22
- Bonar R, Favaloro EJ. Explaining and reducing the variation in inter-laboratory reported values for International Normalised Ratio. Thromb Res. 2017;150:22-9. DOI: 10.1016/j. thromres.2016.12.007
- Clinical and Laboratory Standards Institute (CLSI). Procedures for Validation of INR and Local Calibration of PT/INR Systems; Approved Guideline. CLSI guideline H54-A. Wayne: CLSI; 2005.
- Croatian Chamber of Medical Biochemists. [Harmonizacija laboratorijskih nalaza u području opće medicinske biokemije.] Available at: http://www.hkmb.hr/obavijesti/obavije-sti-index.html. Accessed March 21th 2016. (in Croatian).
- Lippi G, Favaloro EJ. Activated partial thromboplastin time: New tricks for an old dogma. Semin Thromb Hemost. 2008;34:604-11. DOI: 10.1055/s-0028-1104539
- Johnston M, ed. Monitoring Heparin Therapy. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 224-52. DOI: 10.1002/9781118543467.ch21
- Brill-EdvardsP, Gunsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med. 1993;119:104-9. DOI: 10.7326/0003-4819-119-2-199307150-00002
- Marlar RA, Gausman J. The optimum number and types of plasma samples necessary for an accurate activated partial thromboplastin time - based heparin therapeutic range. Arch Pathol Lab Med. 2013;137:77-82. DOI: 10.5858/arpa.2011-0516-OA
- Laposata M, Green D, Van Cott EM, Barrowcliffe TW, Goodnight SH, Sosolik RC. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy; the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. Arch Pathol Lab Med. 1998;122:799-807
- Rodgers GM, Lehman CM, eds. Hemostasis Screening Assays. In: Bennett ST, Lehman CM, Rodgers GM. Laboratory Hemostasis: A Practical Guide for Pathologists. Basel: Springer International Publishing Switzerland; 2007.p.85-101. DOI: 10.1007/0-387-36840-X_5
- Teruya J. Thrombin Time. Available at: https://emedicine.medscape.com/article/2086278-overview . Accessed March 21th 2016.
- Ariëns RA. Fibrin(ogen) and thrombotic disease. J Thromb Haemost. 2013;11:294-305. DOI: 10.1111/jth.12229
- Mackie IJ, Kitchen S, Machin SJ, Lowe GDO. On Behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on fibrinogen assays. Br J Haematol. 2003;121:396-404. DOI: 10.1046/j.1365-2141.2003.04256.x
- van den Besselaar AMHP, van Rijn CJJ, Cobbaert CM, Reijnierse GLA, Hollestelle MJ, Niessen R. et al. Fibrinogen determination according to Clauss: commutability assessment of International and commercial standards and quality control samples. Clin Chem Lab Med. 2017; 55:1761-9. DOI: 10.1515/cclm-2016-1088
- Miesbach W, Schenk J, Alesci S, Lindhoff-Last E. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia. Thromb Res. 2010;126:e428-33. DOI: 10.1016/j.thromres.2010.09.004
- Chitolie A, Mackie IJ, Grant D, Hamilton JL, Machin SM. Inaccuracy of the “derived” fibrinogen measurement. Blood Coagul Fibrinol. 1994;5:955-7. DOI: 10.1097/00001721-199412000-00012
- Olson JD, Cunningham MT, Higgins RA, Eby CS, Brandt JT. D-dimer: simple test, tough problems. Arch Pathol Lab Med. 2013;137:1030-8. DOI: 10.5858/arpa.2012-0296-CP
- Lippi G, Tripodi A, Simundic AM, Favaloro EJ. International survey on D-dimer test reporting: a call for standardization. Semin Thromb Hemost. 2015;41:287-93. DOI: 10.1055/s-0035-1549092
- Clinical and Laboratory Standards Institute (CLSI). Quantitative D-Dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline H59-A. Wayne: CLSI; 2011.
- Oude Elferink RFM, Loot AE, Van de Klashorst CGJ, Hulsebos-Huygen M, Piersma-Wichers M, Oudega R. Clinical evaluation of eight different D-dimer test for the exclusion of deep venous thrombosis in primary care patients. Scand J Clin Lab Invest. 2015;75:230-8. DOI: 10.3109/00365513.2014.993697
- Douma RA, Tan M, Schutgens RE, Bates SM, Perrier A, Legnani C et al. Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica. 2012;97:1507-13. DOI: 10.3324/haematol.2011.060657
- Favaloro EJ, Lippi G. Laboratory reporting of haemostasis assays: The final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis? Clin Chem Lab Med. 2010;48:309-21. DOI: 10.1515/CCLM.2010.061
- Marlar RA, ed. Hemostasis test validation, performance, and reference intervals: international recommendations and guidelines. In: Kitchen S, Olson JD and Preston FE, eds. Quality in Laboratory Hemostasis and Thrombosis, Second Edition. Oxford: John Wiley & Sons, Ltd; 2013. p. 13-21. DOI: 10.1002/9781118543467.ch2
- Castellone DD. Establishing reference intervals in the coagulation laboratory. Int J Lab Hematol. 2017;39:121-27. DOI: 10.1111/ijlh.12661
- Ignjatovic V, Kenet G, Monagle P, on behalf of the Perinatal and Paediatric Haemostasis Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Developmental hemostasis: recommendations for laboratories reporting paediatric samples. J Thromb Haemost. 2012;10:298-300. DOI: 10.1111/j.1538-7836.2011.04584.x
- Tripodi A, Lippi G, Plebani M. How to report results of prothrombin and activated partial thromboplastin times. Clin Chem Lab Med. 2016;54:215-22. DOI: 10.1515/cclm-2015-0657
- Vasikaran S, Sikaris K, Kilpatrick E, French J, Badrick T, Osypiw J, Plebani M. IFCC WG harmonization of quality assessment of interpretative comments. Clin Chem Lab Med. 2016;54:1901-11. DOI: 10.1515/cclm-2016-0709
- Lippi G, Adcock D, Simundic AM, Tripodi A, Favaloro EJ. Critical laboratory values in hemostasis: toward consensus. Ann Med. 2017;49:455-461. DOI: 10.1080/07853890.2016.1278303
- Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest. 2008;133:160S-98S. DOI: 10.1378/chest.08-0670
- Pai M, Moffat KA, Plumhoff E, Hayward CM. Critical values in the coagulation laboratory: results of a survey of the North American Specialized Coagulation Laboratory Association. Am J Clin Pathol. 2011;136:836-41. DOI: 10.1309/AJCP8O8GIPPPNUSH
- Don-Wauchope AC, Chetty VT. Laboratory defined critical value limits: how do hospital physicians perceive laboratory based critical values? Clin Biochem. 2009;42:766-70. DOI: 10.1016/j. clinbiochem.2009.02.016
- Huber AR, Méndez A, Brunner-Agten S. Automation in haemostasis. Hamostaseologie. 2013;33:295-8. DOI: 10.5482/HAMO-12-05-0002